ADAPTIMMUNE THERAPEUTICS PLC shareholders Q3 2023

ADAPTIMMUNE THERAPEUTICS PLC's ticker is ADAP and the CUSIP is 00653A107. A total of 78 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

ADAPTIMMUNE THERAPEUTICS PLC shareholders Q3 2023
NameSharesValueWeighting ↓
CAPTRUST FINANCIAL ADVISORS 21,924$17,1010.00%
Qube Research & Technologies Ltd 21,561$16,8180.00%
Carmichael Hill & Associates, Inc. 525$4100.00%
Investors Research Corp 100$780.00%
Global Retirement Partners, LLC 6,000$4,3650.00%
Lindbrook Capital, LLC 4,610$3,5960.00%
HighMark Wealth Management LLC 287$2240.00%
Tower Research Capital LLC (TRC) 8,037$6,2690.00%
Cutler Group LLC / CA 1,511$10.00%
Beaird Harris Wealth Management, LLC 92$720.00%
JPMORGAN CHASE & CO 1,031,417$804,5060.00%
BARCLAYS PLC 50,061$390.00%
COMMONWEALTH EQUITY SERVICES, LLC 31,875$250.00%
ROYAL BANK OF CANADA 19,025$15,0000.00%
RAYMOND JAMES & ASSOCIATES 10,369$8,0880.00%
UBS Group AG 28,334$22,1000.00%
RHUMBLINE ADVISERS 5,582$4,3520.00%
WEALTH ENHANCEMENT ADVISORY SERVICES, LLC 30,239$23,5860.00%
BNP PARIBAS FINANCIAL MARKETS 4,053$3,1610.00%
TWO SIGMA INVESTMENTS, LP 60,074$46,8580.00%
External links

This page lists ADAPTIMMUNE THERAPEUTICS PLC's shareholders in Q3 2023. To view ADAPTIMMUNE THERAPEUTICS PLC's shareholder history, click here.